This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Dumbest Things on Wall Street This Week: May 10

5. Monster's Gall

Fine, Dennis Herrera. We won't accuse you of playing tit for tat with Monster Beverage (MNST), but that still doesn't make this whole legal game any less childish.

The San Francisco city attorney announced Monday his lawsuit against the energy-drink maker, accusing Monster of marketing its high-caffeine energy drinks to minors despite established health risks. Herrera's move comes a mere week after Monster sued him for demanding the company cut back its caffeine levels and change its ad-campaign. Monster, which Herrera called the "industry's worst offender" when it comes to targeting pre-teens, saw its shares sink over 2% Monday on the news. The stock tumbled another 6% on Wednesday afternoon after Monster missed the Street's Q1 earnings estimate by 9 cents.

"Our lawsuit is not a reaction to their lawsuit," said Herrera. "We were proceeding on this path in the event that we would be unable to come to a resolution."

To which Monster's legal team replied: Hey! No fair you icky attorney! We sued you first! No tag-backs or sue-backs allowed!

OK. They didn't really say that, yet they may as well have, considering the way this whole juvenile drama has unfolded since 14-year-old Anais Fournier died of "cardiac arrhythmia due to caffeine toxicity" after drinking two 710 milliliter cans of Monster Energy drink, in December 2011. The tragic case threw the spotlight onto the energy-drink industry, and by the summer of 2012 it became a cause celebre for slobbering politicians from New York to California seeking a seemingly soft target.


Hey, can you blame the pols for piling on? When the American Academy of Pediatrics and the American Heart Association are on your side, you would think that Monster would fall quicker than Baghdad!

Unbelievably, however, that wasn't the case! Even while being painted as a Frankenstein, Monster refused to be scared off by the pitchfork-wielding politicians. Monster vigorously defended itself in the Fournier case, saying she had a pre-existing heart condition and also repeated its claims that its cans clearly state the required safety warnings.

Most shocking was the Corona, Calif.-based company's decision last week to raise the stakes by launching a preemptive strike against Herrera in the form of a lawsuit. Monster says Herrera's effort poses "undue burdens on interstate commerce" and violates it's constitutionally protected right to "commercial speech." The lawsuit also contends that Herrera is more "motivated by publicity rather than science."

Of course he is you morons! He's a politician! That's what they do. More than that though, he's also the guy holding screen shots from your Web site listing an 11-year-old as a "Monster Army Major" and a 6-year-old as a "Reserve."

Sorry, Monster. That's not science, that's just stupidity. Not to mention the smoking gun in Herrera's case against you.

Or, to continue with the playground-speak: Herrera is rubber and you are glue. So shut your mouths and play nice, because whatever you say bounces off him and sticks to you!

1 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs